GetTopicDetailResponse(id=51ec12909229, topicName=HER2 陽(yáng)性乳腺癌, introduction=, content=曲妥珠單抗 HER2 陽(yáng)性乳腺癌, image=null, comments=0, allHits=68, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Aug 04 09:32:01 CST 2025, time=2025-08-04, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=507139, tagList=[TagDto(tagId=507139, tagName=HER2 陽(yáng)性乳腺癌)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2275932, encodeId=274722e59322b, content=<a href='/topic/show?id=cbef6022e4c' target=_blank style='color:#2F92EE;'>#曲妥珠單抗#</a> <a href='/topic/show?id=51ec12909229' target=_blank style='color:#2F92EE;'>#HER2 陽(yáng)性乳腺癌#</a>, objectTitle=PLOS Medicine：觀察性研究精準(zhǔn)重復(fù)RCT 結(jié)果，曲妥珠單抗對(duì) HER2 陽(yáng)性乳腺癌療效獲雙重驗(yàn)證, objectType=article, longId=890084, objectId=988789008444, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250224/1740391727298_8538692.jpg, objectUrl=/article/show_article.do?id=988789008444, replyNumber=0, likeNumber=25, createdTime=2025-08-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=988789008444, moduleTitle=PLOS Medicine：觀察性研究精準(zhǔn)重復(fù)RCT 結(jié)果，曲妥珠單抗對(duì) HER2 陽(yáng)性乳腺癌療效獲雙重驗(yàn)證, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=988789008444)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-08-04發(fā)表于上海
